Trade-offs between the immune system and other condition dependent life-history traits 33 (reproduction, predator avoidance, and somatic growth) have been well documented in 34 both birds and mammals. However, no studies have examined the impact of immune 35 activation on thermoregulatory performance during acute cold exposure. Because of their 36 high surface-area-to-volume ratios, small birds incur high energetic costs associated with 37 thermoregulation during cold exposure. Consequently, we predicted that the immune 38 system and the thermoregulatory system would compete for energetic resources. To test 39 this, we immunologically challenged adult house sparrows (Passer domesticus) with 5 40 mg/kg of lipopolysaccharide (LPS) to induce an acute phase response (APR) and 41 measured both resting (RMR = minimum metabolic rate) and summit (M sum = maximal 42 metabolic rate during cold exposure) metabolic rates. We found that birds injected with 43 LPS had significantly higher RMR and M sum than birds injected with phosphate buffered 44 saline (PBS), indicating that LPS-treated birds were able to support both the cost of 45 immune activation and that of thermoregulation under conditions eliciting maximal 46 thermogenic performance. These results suggest that, in the absence of a pathogen, birds 47 that experience short-term activation of the immune system have higher energetic costs 48 during cold exposure, but immune activation does not compromise maximum 49 thermoregulatory performance. 50 51
INTRODUCTION 55
Condition dependent life-history traits require organisms to invest energetic resources 56 effects on our results. 148
149

Immune challenge 150
We randomly assigned birds to receive a single injection of either LPS (Sigma#L4005, 151 serotype 055:B5) dissolved in phosphate buffered saline (PBS) or PBS (control). 152
We injected birds with a high LPS dose of 5 mg kg -1 of body weight to maximize the 153 detection of the effects of immune activation on thermogenic performance and acute cold 154 tolerance. We derived this dose from a pilot dose-response study where birds used in the 155 cold challenge study were randomly challenged with either PBS or with varying doses of 156 LPS (1 and 5 mg kg -1 BW). We measured their body temperature (T b ) at the time of 157 injection (0 h) and 3, 6 and 24 h post-injection. We found that the dose of 5 mg kg -1 BW 158 induced a significantly more pronounced and longer lasting bout of hypothermia (3 to 6 h 159 post-injection) than the 1 mg kg -1 BW dose (Fig. 1 ). The birds used for the pilot 160 experiment were given an additional two-week rest period prior to M sum measurements. 161
In small passerine bird species, hypothermia, as opposed to fever, has previously been 162 reported during LPS-challenge (Owen-Ashley et al., 2006; Owen-Ashley and Wingfield, 163 2007) . A 5 mg kg -1 dose of LPS has been used in other avian (Cheng et al., 2004) and 164 small mammal studies (Barsig et al., 1995; Qin et al., 2007) . 165 166
Summit metabolic rate 167
We injected birds with either LPS (n = 6) or PBS (n = 6) 3 h prior to cold challenge. We 168 measured M sum via sliding cold exposure in a helox (79% helium and 21% oxygen) gas 169 mixture (Liknes et al., 2002; Swanson, 2001; Swanson et al., 1996) . We initiated the cold 170 exposure at 0 to -6°C for 15 min, then decreased the bath temperature at a rate of -0.3°C 171 min -1 until a steady decline in oxygen consumption indicative of hypothermia was 172 induced. We modified the initial temperature for each individual, according to body mass 173 (lower temperatures for larger birds), so that hypothermia did not occur too rapidly (< 30 174 min) or too slowly (> 1 h). 175
176
We placed individual birds into a 1.9 l metabolic chamber designed from a paint can with 177 the inner surface painted flat black to provide emissivities near 1.0. The chamber was 178
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to Bartholomew et al. (Bartholomew et al., 1981) , was 1917· ml. We achieved 180 temperature control within the metabolic chamber by immersing it into a bath of water 181 and ethylene glycol (Forma Scientific Model 2095; Marietta, OH, USA), which regulated 182 chamber temperature to ± 0.2°C. Prior to immersion, we flushed the chamber for at least 183 5 min with helox to replace air. We scrubbed incurrent and excurrent gas of water and 184 CO 2 by passing the gas stream through a column of drierite and ascarite. We maintained 185 flow rates of dry, CO 2 -free, helox at 1010-1030· (Dawson and Smith, 1986) . We corrected all values for oxygen consumption to 203 STPD. Tests were conducted between 09:00 h and 12:00 h. Birds were in the chamber for 204 no more than 1 h and no more than two birds were cold-challenged per day. . We considered birds with T b < 37°C as hypothermic. For each bird, we noted the 211 temperature at cold limit (T CL = the temperature producing hypothermia during exposure 212 of an individual bird to a declining series of temperatures) (Saarela et al., 1989) . 213 214 We completed body mass and temperature measurements at the time of injection, 3 h 215 post-injection, immediately after cold challenge, and 24 h after injection. 216 217
Resting metabolic rate 218
We measured RMR using procedures similar to those for M sum measurements except that 219 air was used as the respiratory gas instead of helox. We randomly selected birds to 220 receive LPS or PBS treatments. We measured RMR in LPS (n = 5) and PBS (controls; n 221 = 5) injected birds from 19:00 h to 07:00 h. We injected birds immediately before placing 222 them into the metabolic chamber. We maintained flow rates of dry, CO 2 -free air at 290 223 ml min -1 and kept the chamber temperature at 30°C, which is within the thermal neutral 224 zone for house sparrows (Arens and Cooper, 2004; Hudson and Kimzey, 1966) , 225 throughout the RMR trials. We kept birds within the metabolic chambers overnight for 226 ~12 h. Because we did not fast birds prior to metabolic measurements, and to allow the 227 APR to develop, we excluded the first 3 h of the metabolic trial from our RMR 228 calculations. We recorded oxygen content in the excurrent gas every 5 s and calculated 229 oxygen consumption according to steady state equations (Withers, 1977) 
Data analysis 238
We carried out all statistical analyses using JMP 7.0.1 (SAS Institute Inc., Cary, NC, 239 U.S.A.) and present data as means ± SE. We accepted statistical significance at p ≤ 0.
240
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We analyzed the effects of treatment on RMR and M sum via analysis of variance 241 (ANOVA) and analysis of covariance (ANCOVA) with body mass (measured 242 immediately prior to birds being placed in the metabolic chamber) acting as the covariate. 243
We used repeated measures ANOVAs (RMA) to detect any treatment by time effects on 244 the body mass and body temperature (T b ) of birds sampled at multiple time points, 245 followed by Bonferroni corrected Student's t-test at each time point. Student's t-test were 246 also used for pairwise comparisons of the magnitude of change in body mass and T b , and 247 also to detect variation in the temperature at cold limit (T CL ). 248
249
RESULTS 250
Effects of immune challenge on M sum 251 LPS-treated birds had significantly higher M sum than PBS-treated birds both with 252 (ANCOVA: F 3, 8 = 5.14, P = 0.029) and without (ANOVA: F 1, 10 = 8.14, P = 0.017) 253 body mass included as a covariate ( The Journal of Experimental Biology -ACCEPTED AUTHOR MANUSCRIPT cold challenge there was no significant difference in body mass between LPS and PBS-272 treated birds (t (10) = 2.23, P = 1). However, PBS-treated birds lost significantly more 273 body mass than LPS-treated birds (t (10) = 2.23, P = 0.0014) during cold challenge 274 (change in body mass for birds measured immediately before and after cold challenge). 275
At 24 h post injections there was no significant difference in body mass (t (10) = 2.23, P 276 = 0.97) or T b (t (10) = 2.23, P = 0.31; Table 1 ) between LPS and PBS-treated birds. The 277 temperature producing hypothermia during cold challenge (T CL ) was not significantly 278 different between LPS-treated and PBS-treated birds (t (10) = 2.23, P = 0.81; Fig. 4) . and immune activation during much milder cold exposure treatments. Despite the 299 additive cost of the APR and M sum in this study, the thermogenic performance of cold 300 challenged birds was not affected by immune activation, suggesting that immune 301 challenged birds were able to afford the energetic costs of concurrent activation of both 302
The Journal of Experimental Biology -ACCEPTED AUTHOR MANUSCRIPT thermoregulatory and immune systems, even under conditions eliciting maximal 303 thermoregulatory performance. To our knowledge, this is the first study to examine the 304 effects of immune activation on thermoregulation during acute cold challenge. 305 306 Stimulation of the acute phase response, via LPS, resulted in birds having significantly 307 higher RMR (40% increase) than those challenged with PBS (Fig. 2) . This is in 308 agreement with previous data for avian species, where activation of the immune system 309 resulted in elevated RMR (Marais et al., 2011; Martin et al., 2003) . LPS-treated house 310 sparrows also lost significantly more body mass than control birds during the 12 h period 311 that they spent in the metabolic chamber. Birds in the metabolic chamber did not have 312 access to food or water. As such, the loss of body mass is reflective of birds using their 313 stored energetic resources to maintain bodily functions. In a previous study, the loss of 314 body mass was ameliorated by providing ad libitum access to food and water during 315 immune challenge, suggesting that the energetic consequences of immune activation can 316 be offset by resource availability at temperatures both within and below thermoneutrality 317 
